The Effect of Exercise on Blood Pressure Variability on Peritoneal Dialysis Patients
The Effect of Combined Aerobic and Resistance Exercise on Blood Pressure Variability on Peritoneal Dialysis Patients
1 other identifier
interventional
55
1 country
1
Brief Summary
In China, the chronic kidney disease (CKD) incidence rate is as high as 10.8%. Renal replacement therapy plays an critical role in the later stage of CKD and becomes mandatory, as end-stage renal disease (ESRD) is unavoidable in progressive CKD. Peritoneal dialysis (PD) has becoming an essential alternative treatment for patient with end-stage renal disease (ESRD). Hypertension is common among ESRD patients receiving PD treatment, with a prevalence rate of 80% -90%, It is major cause for cardiovascular related complications and deaths among ESRD patients. Therefore hypertension increases the cardiovascular disease risk among the patients of ESRD and at the same time plays an independent risk for the progression of ESRD. Most studies uses average blood pressure as a risk indicator, but in recent years, more evidence has shown that blood pressure variability (BPV), the degree of fluctuation of blood pressure for a long period, is an additional risk factors for cardiovascular events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2024
CompletedFirst Submitted
Initial submission to the registry
July 23, 2025
CompletedFirst Posted
Study publicly available on registry
August 1, 2025
CompletedAugust 1, 2025
July 1, 2025
6 months
July 23, 2025
July 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Difference between the coefficient of variation of mean daytime Systolic Blood Pressure from the baseline to the end of the study
Change in the coefficient of variation of mean daytime Systolic Blood Pressure as assessed by Ambulatory Blood Pressure Monitoring.
Baseline/12Weeks
Difference between the Coefficient of variation of mean daytime Diastolic Blood Pressure from the baseline to the end of the study
Change in the Coefficient of variation of mean daytime Diastolic Blood Pressure as assessed by Ambulatory Blood Pressure Monitoring
Baseline/12Weeks
Difference between the Coefficient of Variation of mean nighttime Systolic Blood Pressure from the baseline to the end of the study
Change in the Coefficient of Variation of mean nighttime Systolic Blood Pressure as assessed by Ambulatory Blood Pressure Monitoring
Baseline/12Weeks
Difference between the Coefficient of Variation of mean nighttime Diastolic Blood Pressure from the baseline to the end of the study
Change in the Coefficient of Variation of mean nighttime Diastolic Blood Pressure as assessed by Ambulatory Blood Pressure Monitoring.
Baseline/12Weeks
Secondary Outcomes (2)
Difference between the Coefficient of Variation of 24 Hours Systolic Blood Pressure from the baseline to the end of the study
Baseline/12Weeks
Difference between the Coefficient of Variation of 24 Hours Diastolic Blood Pressure from the baseline to the end of the study
Baseline/12Weeks
Study Arms (2)
control group
NO INTERVENTIONRoutine peritoneal dialysis care, health education, daily activity guidance, and dietary counseling were provided in accordance with the dietary guidelines for chronic kidney disease
Exercise group
EXPERIMENTALRoutine peritoneal dialysis care, health education, daily activity guidance, and dietary counseling were provided in a manner consistent with the care given to the control group-to avoid performance bias. In addition to routine basic care and treatment, the exercise group performed a combination of aerobic and resistance exercise
Interventions
Aerobic exercise: The main form is walking(gait), which includes three parts: warm-up, walking, and relaxation. Exercise time and frequency: 30-60 minutes of exercise per day, 3-5 times per week. Resistance exercise: Mainly uses elastic bands to enhance resistance exercise, since the risks of increased intra-abdominal pressure and fluid leakage in peritoneal dialysis patients is high, Investigator considered selective resistance exercise especially for limb and shoulder joint exercises. Patients can choose 3-5 muscle groups based on individual conditions, with each action 10-15 times and maintained for 10 seconds. Start with 2 sets of resistance exercise and then gradually increase to 3-5 sets, with 2-3 minutes of rest between each sets. Exercise frequency and duration: 2 times a week (non-consecutive days), 20 minutes each time.
Eligibility Criteria
You may qualify if:
- Dialysis time ≥ 3 months, a stable condition;
- Age ≥ 18 years old;
- Hypertension (blood pressure\>140 and/or 90 mmHg or currently under antihypertensive drugs), antihypertensive drugs was not changed or replaced during the complete trial;
- Patients with regular and sufficient peritoneal dialysis with kt/v\>1.7, high compliance, and voluntary participation.
You may not qualify if:
- Blood pressure more than - systolic blood pressure ≥ 180mmHg, diastolic blood pressure ≥ 110mmHg;
- Severe anaemia Hb ≤ 60g;
- Cardiac function Class IV - In accordance with The New York Heart Association classification system, patients with severe cardiac disease resulting in inability to perform any physical activity without discomfort (If any physical activity is undertaken, discomfort is increased) or symptoms of cardiac insufficiency or of the anginal syndrome may be present even at rest.
- Using erythropoietin;
- There have been recent acute cardiovascular and cerebrovascular events, including vascular embolism, surgery, trauma, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The affiliated hospital of Xuzhou Medical University
Xuzhou, Jiangsu, 221000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
July 23, 2025
First Posted
August 1, 2025
Study Start
February 2, 2024
Primary Completion
July 30, 2024
Study Completion
October 16, 2024
Last Updated
August 1, 2025
Record last verified: 2025-07